KCNQ4

potassium voltage-gated channel subfamily Q member 4, the group of Potassium voltage-gated channels

Basic information

Region (hg38): 1:40783787-40840452

Previous symbols: [ "DFNA2" ]

Links

ENSG00000117013NCBI:9132OMIM:603537HGNC:6298Uniprot:P56696AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss 2A (Strong), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 2A (Strong), mode of inheritance: AD
  • nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal dominant 2AADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic10369879; 10025409; 16596322; 18030493; 23399560; 23443030; 23451214; 23717403
The onset of deafness appears postlingual

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KCNQ4 gene.

  • not provided (7 variants)
  • Autosomal dominant nonsyndromic hearing loss 2A (6 variants)
  • Rare genetic deafness (3 variants)
  • Nonsyndromic genetic hearing loss (2 variants)
  • Bilateral sensorineural hearing impairment (1 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNQ4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
45
clinvar
9
clinvar
56
missense
6
clinvar
9
clinvar
135
clinvar
7
clinvar
4
clinvar
161
nonsense
1
clinvar
2
clinvar
2
clinvar
5
start loss
0
frameshift
2
clinvar
2
clinvar
1
clinvar
5
inframe indel
1
clinvar
5
clinvar
6
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
8
5
13
non coding
2
clinvar
39
clinvar
38
clinvar
79
Total 10 16 147 91 51

Highest pathogenic variant AF is 0.0000135

Variants in KCNQ4

This is a list of pathogenic ClinVar variants found in the KCNQ4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-40784080-G-T Conflicting classifications of pathogenicity (Jun 04, 2018)282152
1-40784108-C-T Likely benign (Dec 30, 2023)2918010
1-40784120-C-T Likely benign (Jul 17, 2023)1553452
1-40784121-G-A Autosomal dominant nonsyndromic hearing loss 2A • Inborn genetic diseases Uncertain significance (Oct 25, 2023)2033528
1-40784129-T-TCCCCCGCCCGGGGACGC Pathogenic (Sep 20, 2023)2993508
1-40784143-A-C Inborn genetic diseases Uncertain significance (Sep 16, 2021)2250696
1-40784145-GC-AG Uncertain significance (Jun 14, 2022)1949225
1-40784146-C-T Uncertain significance (Apr 12, 2023)2986989
1-40784158-A-C Inborn genetic diseases Uncertain significance (Sep 16, 2021)2250698
1-40784173-C-G Uncertain significance (Feb 21, 2023)3022678
1-40784174-G-A Uncertain significance (Apr 26, 2021)1314888
1-40784200-C-CG Uncertain significance (Jan 30, 2024)3343127
1-40784203-G-A Uncertain significance (Nov 29, 2023)2699804
1-40784230-G-A Inborn genetic diseases Uncertain significance (Jun 24, 2022)2297526
1-40784233-T-C Autosomal dominant nonsyndromic hearing loss 2A Pathogenic/Likely pathogenic (Jun 21, 2024)585006
1-40784236-T-A Inborn genetic diseases Uncertain significance (Apr 27, 2022)2286445
1-40784242-G-A not specified Likely benign (Dec 06, 2017)513457
1-40784248-T-A Uncertain significance (Apr 02, 2020)1218070
1-40784262-C-T Inborn genetic diseases Uncertain significance (Jul 12, 2022)2300813
1-40784268-C-T Inborn genetic diseases Uncertain significance (Aug 10, 2021)2219842
1-40784269-C-T Autosomal dominant nonsyndromic hearing loss 2A • KCNQ4-related disorder Benign/Likely benign (Dec 11, 2023)730845
1-40784271-G-C Inborn genetic diseases Uncertain significance (Sep 13, 2023)2598752
1-40784274-C-T Inborn genetic diseases Uncertain significance (Feb 03, 2022)2275644
1-40784275-C-T Uncertain significance (Dec 16, 2023)3023196
1-40784274-C-CCGGGCTCCGGCT Conflicting classifications of pathogenicity (Aug 16, 2023)680321

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KCNQ4protein_codingprotein_codingENST00000347132 1456441
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4680.5321257250231257480.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.172884120.6990.00002794390
Missense in Polyphen115197.330.582792035
Synonymous1.351561790.8710.00001281465
Loss of Function4.10732.10.2180.00000163343

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009220.0000922
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.00009390.0000924
European (Non-Finnish)0.0001190.000114
Middle Eastern0.0002720.000272
South Asian0.00003310.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probably important in the regulation of neuronal excitability. May underlie a potassium current involved in regulating the excitability of sensory cells of the cochlea. KCNQ4 channels are blocked by linopirdin, XE991 and bepridil, whereas clofilium is without significant effect. Muscarinic agonist oxotremorine-M strongly suppress KCNQ4 current in CHO cells in which cloned KCNQ4 channels were coexpressed with M1 muscarinic receptors.;
Disease
DISEASE: Deafness, autosomal dominant, 2A (DFNA2A) [MIM:600101]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10025409, ECO:0000269|PubMed:10369879, ECO:0000269|PubMed:10571947, ECO:0000269|PubMed:10925378, ECO:0000269|PubMed:21242547}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cholinergic synapse - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;ion channels and their functional role in vascular endothelium;Neuronal System;Voltage gated Potassium channels;Potassium Channels (Consensus)

Recessive Scores

pRec
0.144

Intolerance Scores

loftool
0.0424
rvis_EVS
-0.67
rvis_percentile_EVS
15.76

Haploinsufficiency Scores

pHI
0.129
hipred
Y
hipred_score
0.715
ghis
0.600

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.311

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kcnq4
Phenotype
hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
potassium ion transport;sensory perception of sound;regulation of ion transmembrane transport;inner ear morphogenesis;potassium ion transmembrane transport
Cellular component
plasma membrane;voltage-gated potassium channel complex;basal plasma membrane;integral component of membrane
Molecular function
voltage-gated potassium channel activity;delayed rectifier potassium channel activity;potassium channel activity;protein binding;calmodulin binding